Michael Mayersohn
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Pharmaceutical Science top 0.5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
Papers in
- Pharmacology 34
- Pharmacogenetics and Drug Metabolism 27
- Antibiotics Pharmacokinetics and Efficacy 20
- Co-authors
- Donald Perrier (10 shared papers)Huadong Tang (9 shared papers)Milo Gibaldi (8 shared papers)John Cobby (6 shared papers)D.G. Perrier (15 shared papers)Arturo Lopez‐Anaya (3 shared papers)S. Michael Owens (9 shared papers)Tarundeep Kakkar (3 shared papers)
- Journals
- Journal of Pharmaceutical Sciences (22 papers)Drug Metabolism and Disposition (17 papers)Journal of Pharmacology and Experimental Therapeutics (10 papers)The Journal of Clinical Pharmacology (9 papers)Clinical Pharmacology & Therapeutics (9 papers)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Michael Mayersohn
161 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 155
- Pharmacology 694
- Pharmaceutical Science 474
- Toxicology 124
- Pharmacology 577
- Analytical Chemistry 309
Countries citing papers authored by Michael Mayersohn
This map shows the geographic impact of Michael Mayersohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Mayersohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Mayersohn more than expected).
Fields of papers citing papers by Michael Mayersohn
This network shows the impact of papers produced by Michael Mayersohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Mayersohn. The network helps show where Michael Mayersohn may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Mayersohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 267 | |
| 2 | 1966 | 131 | |
| 3 | 2007 | 115 | |
| 4 | 2005 | 113 | |
| 5 | 1983 | 106 | |
| 6 | 1977 | 105 | |
| 7 | 1974 | 100 | |
| 8 | 1999 | 98 | |
| 9 | 1966 | 92 | |
| 10 | 1982 | 74 | |
| 11 | 2004 | 72 | |
| 12 | 2006 | 71 | |
| 13 | 2003 | 69 | |
| 14 | 1979 | 65 | |
| 15 | 1978 | 59 | |
| 16 | 1972 | 58 | |
| 17 | 1990 | 53 | |
| 18 | 1988 | 53 | |
| 19 | 1974 | 52 | |
| 20 | 1995 | 51 |
About Michael Mayersohn
Michael Mayersohn is a scholar working on Molecular Biology, Pharmacology, Pharmacology, Pediatrics, Perinatology and Child Health and Oncology, having authored 165 papers that have together received 4.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (27 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers), Drug Transport and Resistance Mechanisms (18 papers), Analytical Chemistry and Chromatography (18 papers), Analytical Methods in Pharmaceuticals (18 papers), Pharmaceutical studies and practices (14 papers), Drug Solubulity and Delivery Systems (12 papers) and Neurotransmitter Receptor Influence on Behavior (12 papers). The work is most often cited by research in Pharmacology (694 citations), Pharmaceutical Science (474 citations), Toxicology (124 citations), Pharmacology (577 citations) and Analytical Chemistry (309 citations). Michael Mayersohn has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Donald Perrier, Huadong Tang, Milo Gibaldi, John Cobby, D.G. Perrier, Arturo Lopez‐Anaya, S. Michael Owens, Tarundeep Kakkar, Athiwat Hutchaleelaha and Ramanuj Achari. Their work appears in journals such as Journal of Pharmaceutical Sciences, Drug Metabolism and Disposition, Journal of Pharmacology and Experimental Therapeutics, The Journal of Clinical Pharmacology and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.